Patents Assigned to Brii Biosciences, Inc.
  • Combination therapy for HIV with adenosine derivative and capsid inhibitors
    Patent number: 11890297
    Abstract: The present disclosure is directed to methods of treating or preventing RNA virus infections and retroviral diseases, such as HIV and AIDS, comprising administering to a subject in need an effective amount of (a) a capsid inhibitor and (b) an adenosine derivative disclosed herein. Compositions comprising an effective amount of an adenosine derivative and an effective amount of a capsid (CA) inhibitor are also provided.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: February 6, 2024
    Assignee: Brii Biosciences, Inc.
    Inventors: Lianhong Xu, Zhi Hong
  • Adenosine derivative and pharmaceutical composition comprising the same
    Patent number: 11793827
    Abstract: Disclosed herein are adenosine derivative prodrugs and compositions thereof that can be used for the treatment of HIV infection or RNA virus infection.
    Type: Grant
    Filed: January 25, 2022
    Date of Patent: October 24, 2023
    Assignee: Brii Biosciences, Inc.
    Inventor: Lianhong Xu